Thuy Nguyen
Internal Medicine · Garland, TXNPI 1447362488
Payments from drug & device makers
Across 454 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Amgen$661
- Boehringer Ingelheim$649
- Novo Nordisk$605
- Kowa Pharmaceuticals America, Inc.$603
- AbbVie$590
- plus $4K from 30 others
What the payments were for
- Speaking & faculty fees$401%
- Food & beverage$7,92899%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 75 | $1,226 |
| Amgen | 32 | $661 |
| Boehringer Ingelheim | 38 | $649 |
| Novo Nordisk | 31 | $605 |
| Kowa Pharmaceuticals America, Inc. | 54 | $603 |
| AbbVie(2 entities) | 35 | $590 |
| Amarin Pharma, Inc. | 35 | $572 |
| GSK | 34 | $506 |
| Astellas Pharma US Inc | 14 | $335 |
| Merck | 27 | $332 |
| Galderma Laboratories, L.p. | 2 | $265 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $265 |
| Johnson & Johnson(2 entities) | 10 | $157 |
| Pfizer | 9 | $154 |
| Merz North America, Inc. | 1 | $146 |
| Radius Health, Inc. | 1 | $121 |
| LEO Pharma Inc. | 1 | $94 |
| Lilly USA, LLC | 6 | $94 |
| Sanofi-aventis U.S. LLC | 5 | $88 |
| Ironwood Pharmaceuticals, Inc | 5 | $83 |
| Jazz Pharmaceuticals Inc. | 4 | $71 |
| Biofire Diagnostics, LLC | 1 | $40 |
| Eisai Inc. | 2 | $40 |
| Dexcom, Inc. | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Si-bone, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $22 |
| Exact Sciences | 1 | $22 |
| Alk-abello, Inc | 1 | $19 |
| Baxter Healthcare | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Vivus LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Concordia Pharmaceuticals Inc. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,968 in reported general payments places this provider in the 90th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 20 | $47,824 |
| FarxigaDapagliflozin Propanediol | 25 | $35,875 |
| VascepaIcosapent Ethyl | 31 | $25,590 |
| JanumetSitagliptin Phos/Metformin Hcl | 22 | $25,036 |
| MounjaroTirzepatide | 15 | $22,337 |
| ProliaDenosumab | 11 | $19,420 |
| ZenpepLipase/Protease/Amylase | 19 | $18,730 |
| Omega-3 Acid Ethyl Esters | 26 | $6,856 |
| Vilazodone Hcl | 11 | $2,128 |
| Paroxetine Hcl | 65 | $1,977 |
| Telmisartan | 44 | $703 |
| Minoxidil | 29 | $577 |
| Atorvastatin Calcium | 78 | $500 |
| Triamcinolone Acetonide | 15 | $461 |
| Gabapentin | 25 | $410 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus | $605 | $47,82420 claims |
| AstraZenecaFarxiga | $1,226 | $35,87525 claims |
| MerckJanumet | $332 | $25,03622 claims |
| Lilly USA, LLCMounjaro, Olanzapine | $94 | $22,49128 claims |
| AmgenProlia | $661 | $19,42011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Garland
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.